Skip to main content
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.670
+0.350 (8.10%)
At close: Mar 9, 2026, 4:00 PM EDT
4.690
+0.020 (0.43%)
After-hours: Mar 9, 2026, 4:08 PM EDT

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $861.00K in the quarter ending September 30, 2025, a decrease of -12.77%. This brings the company's revenue in the last twelve months to $2.82M, up 6.46% year-over-year. In the year 2024, Orchestra BioMed Holdings had annual revenue of $2.64M, down -4.42%.

Revenue (ttm)
$2.82M
Revenue Growth
+6.46%
P/S Ratio
86.36
Revenue / Employee
$40,257
Employees
70
Market Cap
262.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.64M-122.00K-4.42%
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-551.79%
Dec 31, 2021-782.00K-6.49M-113.71%
Dec 31, 20205.70M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sol-Gel Technologies 18.97M
Ovid Therapeutics 6.61M
Surrozen 3.60M
Abeona Therapeutics 400.00K
Inhibikase Therapeutics 1.00
Revenue Rankings

OBIO News

More News